Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Lancet (London, England)
|
September 27, 2025
Ivonescimab versus pembrolizumab in PD-L1-positive NSCLC
Mingyang Xue, Wenyi Jin
Frontiers in Immunology
|
March 21, 2025
Editorial: Immunological precision therapeutics: integrating multi-omics technologies and comprehensive approaches for personalized immune intervention
Mingyang Xue, Wenyi Jin
Frontiers in Immunology
|
May 9, 2025
Editorial: The role of ubiquitination in disease development, progression, and prognosis
Mingyang Xue, Wenyi Jin
Lancet (London, England)
|
June 25, 2026
AI-supported mammography screening: measuring benefit
Yihang Chu, Chen Niu, Wenyi Jin
Journal of Psychosomatic Research
|
May 19, 2021
Associations between fear of falling and activity restriction and late life depression in the elderly population: Findings from the Irish longitudinal study on ageing (TILDA)
Qian Yao, Wenyi Jin, Yan Li
The New England Journal of Medicine
|
August 20, 2025
Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
Susu Luo, Hui Liu, Wenyi Jin
The Lancet. Oncology
|
October 31, 2024
Concerns regarding the AtTEnd trial in advanced endometrial carcinoma
Queran Lin, Wenyi Jin, Dan Shan
Lancet (London, England)
|
April 5, 2026
Perioperative immunotherapy for resectable hepatocellular carcinoma
Wenyi Jin, Mingyang Xue, Susu Luo
Oncology Research
|
April 29, 2025
Research progress on cancer-associated fibroblasts in osteosarcoma
Liwen Feng, Yuting Chen, Wenyi Jin
Biomed Research International
|
April 9, 2021
Association between CT-Quantified Body Composition and Recurrence, Survival in Nonmetastasis Colorectal Cancer Patients Underwent Regular Chemotherapy after Surgery
Piaopaio Ying, Wenyi Jin, Xiaoli Wu, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Lancet (London, England)
|
September 27, 2025
Ivonescimab versus pembrolizumab in PD-L1-positive NSCLC
Mingyang Xue, Wenyi Jin
Frontiers in Immunology
|
March 21, 2025
Editorial: Immunological precision therapeutics: integrating multi-omics technologies and comprehensive approaches for personalized immune intervention
Mingyang Xue, Wenyi Jin
Frontiers in Immunology
|
May 9, 2025
Editorial: The role of ubiquitination in disease development, progression, and prognosis
Mingyang Xue, Wenyi Jin
Lancet (London, England)
|
June 25, 2026
AI-supported mammography screening: measuring benefit
Yihang Chu, Chen Niu, Wenyi Jin
Journal of Psychosomatic Research
|
May 19, 2021
Associations between fear of falling and activity restriction and late life depression in the elderly population: Findings from the Irish longitudinal study on ageing (TILDA)
Qian Yao, Wenyi Jin, Yan Li
The New England Journal of Medicine
|
August 20, 2025
Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
Susu Luo, Hui Liu, Wenyi Jin
The Lancet. Oncology
|
October 31, 2024
Concerns regarding the AtTEnd trial in advanced endometrial carcinoma
Queran Lin, Wenyi Jin, Dan Shan
Lancet (London, England)
|
April 5, 2026
Perioperative immunotherapy for resectable hepatocellular carcinoma
Wenyi Jin, Mingyang Xue, Susu Luo
Oncology Research
|
April 29, 2025
Research progress on cancer-associated fibroblasts in osteosarcoma
Liwen Feng, Yuting Chen, Wenyi Jin
Biomed Research International
|
April 9, 2021
Association between CT-Quantified Body Composition and Recurrence, Survival in Nonmetastasis Colorectal Cancer Patients Underwent Regular Chemotherapy after Surgery
Piaopaio Ying, Wenyi Jin, Xiaoli Wu, et al.
Page
of 8